1. Home
  2. MSIF vs ABCL Comparison

MSIF vs ABCL Comparison

Compare MSIF & ABCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MSIF
  • ABCL
  • Stock Information
  • Founded
  • MSIF 2011
  • ABCL 2012
  • Country
  • MSIF United States
  • ABCL Canada
  • Employees
  • MSIF N/A
  • ABCL N/A
  • Industry
  • MSIF
  • ABCL Biotechnology: Pharmaceutical Preparations
  • Sector
  • MSIF
  • ABCL Health Care
  • Exchange
  • MSIF NYSE
  • ABCL Nasdaq
  • Market Cap
  • MSIF 732.7M
  • ABCL 772.9M
  • IPO Year
  • MSIF N/A
  • ABCL 2020
  • Fundamental
  • Price
  • MSIF $16.20
  • ABCL $2.13
  • Analyst Decision
  • MSIF Buy
  • ABCL Strong Buy
  • Analyst Count
  • MSIF 5
  • ABCL 4
  • Target Price
  • MSIF $18.50
  • ABCL $8.33
  • AVG Volume (30 Days)
  • MSIF 33.1K
  • ABCL 4.1M
  • Earning Date
  • MSIF 05-12-2025
  • ABCL 05-08-2025
  • Dividend Yield
  • MSIF 4.58%
  • ABCL N/A
  • EPS Growth
  • MSIF N/A
  • ABCL N/A
  • EPS
  • MSIF 1.50
  • ABCL N/A
  • Revenue
  • MSIF $134,105,000.00
  • ABCL $23,114,000.00
  • Revenue This Year
  • MSIF $11.88
  • ABCL N/A
  • Revenue Next Year
  • MSIF $12.55
  • ABCL $36.62
  • P/E Ratio
  • MSIF $10.51
  • ABCL N/A
  • Revenue Growth
  • MSIF N/A
  • ABCL N/A
  • 52 Week Low
  • MSIF $14.01
  • ABCL $1.89
  • 52 Week High
  • MSIF $18.00
  • ABCL $4.20
  • Technical
  • Relative Strength Index (RSI)
  • MSIF N/A
  • ABCL 45.42
  • Support Level
  • MSIF N/A
  • ABCL $1.98
  • Resistance Level
  • MSIF N/A
  • ABCL $2.08
  • Average True Range (ATR)
  • MSIF 0.00
  • ABCL 0.10
  • MACD
  • MSIF 0.00
  • ABCL 0.01
  • Stochastic Oscillator
  • MSIF 0.00
  • ABCL 48.15

About MSIF MSC INCOME FUND INC

MSC Income Fund Inc is a non-diversified closed-end management investment company. The investment objective is to generate current income through debt and equity investments and the secondary objective is to generate long-term capital appreciation through such investments. The company invests in senior secured term loans, second lien loans, and mezzanine debt and selected equity investments issued by lower middle-market and middle-market companies.

About ABCL AbCellera Biologics Inc.

AbCellera Biologics Inc is an antibody discovery and development engine that's specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic and patients sooner. With the integrated AbCellera platform, the company's experts search a wide range of diverse antibodies to select the effective and developable leads fast and set partners up for enduring success. The company has extensive experience forging partnerships with emerging biotechs and pharmaceutical companies. AbCellera leverages proprietary hardware, software, and tools along with the latest data science, to operate as strategic partners and help develop optimized solutions faster for any program.

Share on Social Networks: